To include your compound in the COVID-19 Resource Center, submit it here.
Lpath began the open-label, U.S. Phase Ib/IIa PEDigree trial to evaluate 0.5 and
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury